Publications by authors named "R Abu-Hijlih"
Article Synopsis
- Adult medulloblastoma is uncommon, and treatment insights are mostly drawn from studies of pediatric cases; this study analyzed adult cases treated at King Hussein Cancer Center to understand clinical features and outcomes.
- The study included 53 patients aged 18 and older, with comprehensive assessments of disease characteristics and treatment responses over a median follow-up of 70 months, noting that 37.7% of patients died during this period.
- The findings highlighted significant correlations between patient outcomes and factors such as the extent of surgery and risk status, while molecular subgrouping did not predict survival outcomes, indicating a need for more aggressive treatment in high-risk patients.
Purpose: To evaluate clinical outcomes and prognostic factors in non-metastatic oral cavity squamous cell carcinoma (OCSCC) patients who underwent surgery with or without adjuvant therapy.
Methods: From 2007 and 2018, 116 patients were analyzed. The primary endpoint was overall survival (OS), and secondary endpoints were disease-free survival (DFS), local failure (LF), regional failure (RF), and distant metastases (DM).
Article Synopsis
- * A study reviewed 166 patient records, focusing on 143 without prior central nervous system (CNS) involvement, and analyzed the outcomes of those who received TBI with or without CRB.
- * Results showed no significant differences in relapse rates or survival between patients with and without CRB, indicating that adding CRB may not provide extra benefits in preventing relapses after transplantation.
Background: Germline genetic testing (GGT) has significant implications in the management of patients with prostate cancer (PCa). Herein, we report on patterns and frequency of pathogenic/likely pathogenic germline variants (P/LPGVs) among newly diagnosed Arab patients with PCa.
Methods: Patients meeting the National Comprehensive Cancer Network (NCCN) eligibility criteria for GGT were offered a 19-gene PCa panel or an expanded 84-gene multi-cancer panel.
Purpose: Metastatic prostate cancer (Pca) is a complex disease with diverse clinical characteristics and outcomes across the geographical distribution. Herein, we present a series of patients from the Middle East, aiming at identifying disease outcomes and prognostic factors specific to this regional context.
Methods And Materials: This is a retrospective study of patients with metastatic Pca, diagnosed at King Hussein Cancer Center, Jordan, between 2006 and 2018.